# AdHerencE to Treatment and quAlity of Life in COPD

> **NCT03299673** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 600 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Compliance, Patient
- Quality of Life

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03299673
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2018-12-05
- **Final completion:** 2018-12-05
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299673, "AdHerencE to Treatment and quAlity of Life in COPD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03299673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*